Skip to main content
Sun Pharmaceutical Industries Ltd. logo

Sun Pharmaceutical Industries Ltd. — Investor Relations & Filings

Ticker · SUNPHARMA ISIN · INE044A01036 LEI · 335800KJ7GE29LB4SS73 BSE.NS Manufacturing
Filings indexed 1,411 across all filing types
Latest filing 2025-10-14 Environmental & Social …
Country IN India
Listing BSE.NS SUNPHARMA

About Sun Pharmaceutical Industries Ltd.

https://sunpharma.com/

Sun Pharmaceutical Industries Ltd. is a global leader in specialty generic pharmaceuticals, focused on developing, manufacturing, and marketing a comprehensive range of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company’s extensive portfolio covers diverse therapeutic segments, including cardiology, psychiatry, neurology, gastroenterology, ophthalmology, dermatology, and orthopedics. It provides high-quality, affordable medicines across more than 100 markets worldwide, serving both chronic and acute care needs. A significant emphasis is placed on research and development to produce complex generics and innovative specialty products. The organization maintains a robust global manufacturing footprint, operating facilities that comply with stringent international regulatory standards. Its offerings encompass generics, branded generics, specialty medications, and over-the-counter products, aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Updates
Environmental & Social Information Classification · 100% confidence The document is titled 'ESG Overview for FY 2024-25' and covers the company's Environmental, Social, and Governance (ESG) performance for the fiscal year 2024-25. It includes detailed sections on environmental metrics, social initiatives, governance structure, board composition, and corporate governance practices. The document is comprehensive and contains substantive data and analysis related to ESG factors rather than just a brief announcement or summary. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a regulatory filing or certification. The focus on ESG performance aligns with the definition of Environmental & Social Information (SR). Therefore, the appropriate classification is Environmental & Social Information (SR).
2025-10-14 English
Scheme of Arrangement
Regulatory Filings
2025-10-08 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate submitted pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. It confirms the dematerialisation of securities for the quarter ended 30 September 2025. The document is a certificate from the Registrar & Share Transfer Agent to the company, confirming compliance with regulatory requirements related to securities dematerialisation. It does not contain financial statements, management discussion, or detailed financial data. It is primarily a regulatory compliance certificate. The document length is short (3014 characters) and it is a confirmation certificate, not a full report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance document that does not fit other specific categories.
2025-10-07 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, concerning newspaper advertisements related to the Investor Education and Protection Fund (IEPF) Authority's campaign to prevent transfer of unclaimed dividends to the IEPF. It includes details about the campaign, communication efforts by the company, and attached newspaper clippings as annexure. There are no financial statements, earnings data, management discussion, or other report content. The document is a regulatory announcement informing the stock exchanges and public about the company's compliance and awareness activities related to unclaimed dividends and the IEPF campaign. It is not a financial report, earnings release, or management report. It fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance disclosure under SEBI regulations.
2025-09-24 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short announcement from Sun Pharmaceutical Industries Limited regarding the closure of the trading window in compliance with the company's Code of Conduct for Prohibition of Insider Trading. It specifies the period during which trading in the company's shares will be restricted, linked to the upcoming declaration of unaudited financial results for the quarter and half year ended 30 September 2025. The document does not contain any financial data, detailed report, or results itself, but rather informs about the trading restrictions ahead of the financial results announcement. The length is only 1325 characters, indicating it is a brief notice rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance-related notices that do not fit other specific categories.
2025-09-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the schedule of analyst and institutional investor meetings. It explicitly states it is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content does not include any financial data, report, or detailed presentation but is rather an announcement of upcoming investor engagement activities. The document length is only 1597 characters, which is quite short and fits the pattern of a regulatory announcement rather than a full report or presentation. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-09-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.